Shares of Horizon Therapeutics Gain After FTC Pauses Legal Challenge to Amgen Acquisition
Horizon Therapeutics shares rise as FTC pauses legal challenge to Amgen's acquisition, potentially l...
News
Tesla's Stock Dips Below Key Resistance Level
Tesla's stock experiences a 4.9% decline, falling below a crucial resistance level. Technical analys...
Clarence L. Polk
Vietnam Lifts Restriction on Canadian Cereal Grains
Vietnam has removed the restriction on Canadian cereal grains, allowing trade to resume and strength...
Clarence L. Polk
Anheuser-Busch InBev S.A. ADR Shows Positive Momentum
Anheuser-Busch InBev stock demonstrates positive momentum in the market, inching higher and showcasi...
Clarence L. Polk
Proof of Transformative Weight-Loss Drugs in Healthcare
New evidence supports the transformative potential of weight-loss drug Wegovy in healthcare. Obese h...
Clarence L. Polk
Netflix's Competitive Advantage amid Rising Prices and Lower Content Spending
Loop Capital analyst believes Netflix's larger pipeline of unreleased content and global production...
Clarence L. Polk
Hibbett Reports Strong Q2 Results
Hibbett Inc. exceeds profit expectations and reaffirms full-year guidance, navigating market challen...
Clarence L. Polk
Marvell Technology: Disappointment in Lack of Beat-and-Raise
Marvell Technology faces disappointment as shares decline, analysts stay bullish on AI growth. Categ...
Clarence L. Polk
Affirm Holdings Inc. Exceeds Expectations with Strong Financial Results
Affirm Holdings Inc. posts strong financial results, beating expectations and driving stock value up...
Clarence L. Polk
Dollar Tree Inc.'s Stock Drops in Pre-Market Trade
Dollar Tree Inc.'s stock experienced an 8.6% decline in premarket trade after the release of its Q2...
Clarence L. Polk
More Articles
All Rights Reserved © 2024